Our series, Biotechnology: Beyond Imagination, highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Our next feature looks at Alnylam Pharmaceuticals, a biotechnology company working on treatments for diseases that were once thought to be “undruggable”.
Beyond Imagination Member Spotlight: Alnylam Pharmaceuticals
Biotechnology companies around the world make it their mission to solve the world’s most complex medical issues and unmet medical needs—diseases considered “undruggable” by modern science. Alnylam Pharmaceuticals, a Massachusetts-based company, is working to change this for patients with certain genetic, cardio-metabolic, infectious and central nervous system (CNS) and ocular diseases...
